Molecular Partners is a clinical-stage biopharmaceutical company that focuses on the discovery, development, and commercialization of biopharmaceutical products. The Company also develops designed ankyrin repeat protein platform therapies used in ophthalmology, oncology, inflammation, and other therapeutic treatments.
|Employees (est.) (May 2021)||145||(+2%)|
|Share Price (Jun 2021)||CHF23.7|
Market capitalization (4-Jun-2021)
Closing stock price (4-Jun-2021)
When was Molecular Partners founded?
Molecular Partners was founded in 2004.
Who are Molecular Partners key executives?
Molecular Partners's key executives are Michael Tobias Stumpp, Patrick Amstutz and Andreas Emmenegger.
How many employees does Molecular Partners have?
Molecular Partners has 145 employees.
Who are Molecular Partners competitors?
Competitors of Molecular Partners include BioSpecifics Technologies, Abliva and Nordic Nanovector.
Where is Molecular Partners headquarters?
Molecular Partners headquarters is located at 14 Wagistrasse, Zürich-Schlieren.
Where are Molecular Partners offices?
Molecular Partners has offices in Zürich-Schlieren and Cambridge.
How many offices does Molecular Partners have?
Molecular Partners has 2 offices.
Receive alerts for 300+ data fields across thousands of companies